West Pharmaceutical Services (WST) : Hermes Investment Management Ltd scooped up 150,064 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 22, 2016. The investment management firm now holds a total of 1,078,867 shares of West Pharmaceutical Services which is valued at $84,173,203.West Pharmaceutical Services makes up approximately 1.64% of Hermes Investment Management Ltd’s portfolio.
Other Hedge Funds, Including , Parametrica Management Ltd added WST to its portfolio by purchasing 4,539 company shares during the most recent quarter which is valued at $354,133. West Pharmaceutical Services makes up approx 0.51% of Parametrica Management Ltd’s portfolio.Checchi Capital Advisers boosted its stake in WST in the latest quarter, The investment management firm added 2,900 additional shares and now holds a total of 2,907 shares of West Pharmaceutical Services which is valued at $226,804. West Pharmaceutical Services makes up approx 0.06% of Checchi Capital Advisers’s portfolio. Cibc World Markets added WST to its portfolio by purchasing 8,915 company shares during the most recent quarter which is valued at $695,548.Sonora Investment Management reduced its stake in WST by selling 808 shares or 26.17% in the most recent quarter. The Hedge Fund company now holds 2,280 shares of WST which is valued at $176,586. West Pharmaceutical Services makes up approx 0.10% of Sonora Investment Management’s portfolio.
West Pharmaceutical Services opened for trading at $79.96 and hit $81.13 on the upside on Friday, eventually ending the session at $80.28, with a gain of 0.35% or 0.28 points. The heightened volatility saw the trading volume jump to 3,78,482 shares. Company has a market cap of $5,867 M.
On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).